Document is current
Any future updates will be listed below
-
Authors
Sun, Cong https://orcid.org/0000-0003-1786-7420
Xie, Chu https://orcid.org/0000-0003-1206-3124
Cheng, Bing-Zhen
Jiang, Zi-Ying
Wu, Pei-Huang
Fang, Xin-Yan
Li, Peng-Lin
Tian, Xian-Shu
Zhou, Hang
Yang, Yan-Lin
Wang, Jing
Sui, Sen-Fang https://orcid.org/0000-0001-5253-2592
Liu, Zheng https://orcid.org/0000-0001-6952-3406
Zeng, Mu-Sheng https://orcid.org/0000-0003-3509-5591
- License Information
-
More Information
Article History
Received: 24 June 2025
Accepted: 26 January 2026
First Online: 2 February 2026
Competing interests
: The authors declare that patent applications have been submitted referring to the gB monoclonal antibody Fab5 (China invention patent application number: 2024119048839, with M.-S.Z., C.S. and C.X. as inventors; PCT application number: PCT/CN2025/144285, with M.-S.Z., C.S. and C.X. as inventors). The other authors declare no competing interests.
